The use of psychedelic substances in mental health treatment has been studies for many years. Modern use of Ketamine, explored in past episodes, has become common enough to be evaluated as a best practice treatment and is beginning to gain ground with insurance reimbursement. The use of MDMA and Psilocybin mushrooms in treatment of Depression, PTSD, and other disorders is showing fascinating results in research.  Chris Tittle is a psychotherapist in Sisters Oregon, and is educated and certified in the use of psychedelics in mental health management. He joins the program to discuss current theories, research, and training for mental health clinicians in this area.  Follow Chris' work and private telehealth practice at https://motivatedmentalperformance.com/  --- Follow the Broken Brain on Facebook and Twitter @breakabrain, or on IG @brainiacsahoy. If you want to help keep the virtual lights on, check out www.dwighthurst.com/support